Breast cancer molecular subtypes are defined by the expression of hormone receptors such as estrogen receptors (ER+) or progesterone receptors (PR+), human epidermal receptor 2 (HER2+), and triple-negative breast cancer (TNBC; which is ER−, PR−, HER2−). Here, ESR1 is linked to breast carcinoma.